Food and Drug OrganizationF
Continue reading...
U.S. Food and Drug Administration Approves Opdivo® (nivolumab) plus Yervoy® (ipilimumab)...
U.S. Food and Drug Administration Approves Opdivo® (nivolumab) plus Yervoy® (ipilimumab) as a First-Line Treatment for Unresectable or Metastatic Hepatocellular Carcinoma
Bristol Myers Squibb (NYSE: BMY)...
US FDA to phase out animal testing in drug development
US FDA to phase out animal testing in drug development
The U.S. Food and Drug Administration said on Thursday it plans to replace animal...
US FDA approves syringe version of Argenx’s immune disorder drug
US FDA approves syringe version of Argenx's immune disorder drug
The U.S. Food and Drug Administration has approved a prefilled syringe version of Netherlands-based Argenx...
Novartis drug approved for adults with IgAN
Novartis drug approved for adults with IgAN
The U.S. Food and Drug Administration (FDA) has approved Novartis’ oral drug for adults with a serious kidney...
US FDA approves Amgen’s Uplizna as first treatment for rare immune...
US FDA approves Amgen's Uplizna as first treatment for rare immune disorder
The U.S. Food and Drug Administration has approved expanded use of Amgen's (AMGN.O),...
US FDA approves freeze-dried version of Bavarian Nordic’s mpox, smallpox vaccine
US FDA approves freeze-dried version of Bavarian Nordic's mpox, smallpox vaccine
Denmark's Bavarian Nordic (BAVA.CO), opens new tab said on Monday the U.S. Food and Drug Administration...
Vykat XR approved for genetic binge eating disorder
For the first time/
Vykat XR approved for genetic binge eating disorder
The U.S. Food and Drug Administration (FDA) on Wednesday approved Soleno Therapeutics’ drug to...
Subscribe for Exclusive Access
Discover Trending Content
Explore the latest and most talked-about articles, videos, and stories that are capturing the internet's attention. From breaking news to fascinating features, our curated trending content keeps you informed, entertained, and inspired, making it the perfect destination for staying in the know.